Captopril: Difference between revisions

Jump to navigation Jump to search
David Canner (talk | contribs)
No edit summary
No edit summary
 
Line 1: Line 1:
<applet  load="" size="430" color="" frame="true"  spin="on" Scene ="Captopril/Captopril/2" align="right" caption="Captopril, also known as Capoten"/>
<StructureSection load='' size='340' side='right' caption='Captopril, also known as Capoten' scene='Captopril/Captopril/2'>
===Better Known as: Capoten===
===Better Known as: Capoten===
* Marketed By: Bristol-Myers Squibb<br />
* Marketed By: Bristol-Myers Squibb<br />
Line 11: Line 11:
===Mechanism of Action===
===Mechanism of Action===
Extensive research has validated a pathological role for Angiotensin II in cardiac, renal and vascular diseases. <ref>PMID:17083068</ref> Bradykinin, a small peptide that counterbalance the effects of Angiotensin II by acting as a strong vasodilator upon binding AT2, is degraded by the same ACE-1 enzyme. Since ACE-1 is the primary producer of Angiotensin II and primary degrader of Bradykinins, inhibition of ACE-1 has proven an effective treatment for Hypertension and Congestive Heart Failure. Captopril binds to the ACE-1 binding site of <scene name='Captopril/Ace/1'>Angiotensin-Converting enzyme</scene>, preventing ACE-1 from binding angiotensin. Captopril,<scene name='Captopril/Captopril_binding/1'> binds ACE-1 precisely</scene>, forming electrostatic interactions with His 353, Glu 384, Lys 511, His 513 and Tyr 520, along with zinc cation. <ref>PMID:15236580</ref>
Extensive research has validated a pathological role for Angiotensin II in cardiac, renal and vascular diseases. <ref>PMID:17083068</ref> Bradykinin, a small peptide that counterbalance the effects of Angiotensin II by acting as a strong vasodilator upon binding AT2, is degraded by the same ACE-1 enzyme. Since ACE-1 is the primary producer of Angiotensin II and primary degrader of Bradykinins, inhibition of ACE-1 has proven an effective treatment for Hypertension and Congestive Heart Failure. Captopril binds to the ACE-1 binding site of <scene name='Captopril/Ace/1'>Angiotensin-Converting enzyme</scene>, preventing ACE-1 from binding angiotensin. Captopril,<scene name='Captopril/Captopril_binding/1'> binds ACE-1 precisely</scene>, forming electrostatic interactions with His 353, Glu 384, Lys 511, His 513 and Tyr 520, along with zinc cation. <ref>PMID:15236580</ref>
 
</StructureSection>
===Pharmacokinetics===
===Pharmacokinetics===
<table style="background: cellspacing="0px"  align="" cellpadding="0px" width="42%">  
<table style="background: cellspacing="0px"  align="" cellpadding="0px" width="42%">  

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

David Canner, Alexander Berchansky